Objective: Angiotensin II has a critical role in the regulation of blood pressure and cell growth and excess activity of the peptide is implicated in the pathogenesis of salt-induced cardiovascular injury. On the other hand, the role of counteracting angiotensin-(17) in cardiac structural and functional responses to high salt diet has not been elucidated. Therefore, the present study examined the changes in cardiac angiotensin-(17), its forming enzyme angiotensin converting enzyme 2 (ACE2) and receptor mas in response to a high salt diet in spontaneously hypertensive rats (SHR). Methods: Eight-week-old male spontaneously hypertensive rats (SHR) were given an 8% salt diet for 5 weeks (n ¼ 8). Age-and gender-matched controls received standard chow (n ¼ 6). Results: Salt excess increased arterial pressure (p < 0.05) and plasma renin and angiotensin II concentrations (p < 0.05). Salt-induced left ventricular remodeling and diastolic dysfunction were associated with diminished levels of angiotensin-(17) in the heart (p < 0.05) and no changes in cardiac angiotensin II levels. Exposure to high salt intake decreased cardiac ACE2 mRNA and protein level (p < 0.05). There was no difference in the protein levels of angiotensin II type 1 and mas receptors between the two experimental groups. Conclusion: The adverse cardiac effects of excessive salt intake may result not only from the undesirable action of angiotensin II but may also be a consequence of diminished protective effects of the angiotensin-(17).
Introduction
Angiotensin II (Ang II) has a critical role in the regulation of blood pressure and cellular growth and excess activity of the peptide is implicated in the pathogenesis of salt-induced cardiovascular and renal injury [Ahn et al. 2004; Inada et al. 2001; Takeda et al. 2001; Kreutz et al. 1995; Stier, Jr. et al. 1991] . However, the role of counteracting angiotensin-(17) ) in cardiac structural and functional responses to high salt diet has not been elucidated. Ang-(17) exerts vasodilatory, antiproliferative, and antifibrotic action through activation of the mas receptor (mas) [Ferrario et al. 2005b; Tallant et al. 2005 Tallant et al. , 2003 ] and the reduced counterbalancing effects of the heptapeptide may be involved in salt-related cardiovascular injury. Various Ang-(17)-forming enzymes are part of the biochemical cascade of the renin angiotensin system, most of them using angiotensin I (Ang I) as a substrate [Ferrario et al. 2005b; Chappell et al. 1994; Yamamoto et al. 1992] . However, a recent study from our laboratory demonstrated a predominant role of the angiotensin converting enzyme (ACE) homologue, ACE2, in the cardiac production of Ang-(17) in hypertensive animals [Trask et al. 2007] . Therefore, the present study examined the changes in cardiac ACE2/Ang-(17)/mas axis in response to high salt diet in spontaneously hypertensive rats (SHR).
humidity-controlled room with a 12 h light/dark cycle. All rats were handled in accordance with National Institute of Health guidelines; our Institutional Animal Care and Use Committee approved the study in advance. The rats were randomly divided into two groups to receive either a control (1% NaCl; n ¼ 6) or a high salt (8% NaCl; n ¼ 8) diet for the ensuing 5 weeks.
Blood pressure and urinary measurements Systolic blood pressure was assessed by tail-cuff plethysmography (Hatteras Instruments, Cary, NC) during a baseline period followed by weekly measurements in rats trained beforehand. Twenty-four-hour urine output and protein (Bio-Rad protein assay) and sodium excretion (Nova Biomedical automated electrolyte analyzer, Waltham, MA) were assessed at the end of the study period.
Echocardiography
Transthoracic echocardiography was performed in rats anesthetized with a combination of ketamine/xylazine (50 mg/kg/5 mg/kg; i.m.) using a commercially available sector scanner equipped with a 12 MHz phased-array transducer (Envisor, Philips Medical Systems, Andover, MA) [Groban et al. 2008] . Left ventricular (LV) M-mode images were obtained in a two-dimensional short axis view close to the papillary muscles. Posterior wall thicknesses at end diastole (PWTd) and LV end-diastolic and end-systolic dimensions (ESD, EDD) were measured according to the American Society for Echocardiography leading-edge method [Sahn et al. 1978] . The percentage of LV fractional shortening (FS), an index of global systolic function, was calculated as ([LVDD LVSD]/LVDD) Â 100. Mitral inflow measurements of early and late filling velocities (E and A, respectively), deceleration slope (E dec slope), and early deceleration time (E dec time) were obtained using pulsed Doppler, with the sample volume placed at the tips of mitral leaflets from an apical four-chamber orientation. Doppler tissue imaging to assess early mitral valve septal annular velocities (e 0 ) was also obtained from the four-chamber view. All systolic and diastolic indices are the average of at least five consecutive cardiac cycles to minimize beatto-beat variability.
Histopathology and plasma and tissue measurements After echocardiographic analysis was done the rats were allowed to recover for 5 days and trunk blood was collected from decapitated animals. After blood collection, the hearts were removed and weighed. The midportion of the heart was then fixed in 4% paraformaldehyde, dehydrated by routine methods, and embedded in paraffin for subsequent histological study. The investigator, blinded to the experimental groups, determined the myocardial volume fraction occupied by fibrillar collagen by quantitative morphometry using an automated image-analysis system (Spot Advanced software 4.0.9) in sections stained with collagen-specific picrosirius red [Varagic et al. 2006 ]. Paraffin-embedded kidney sections were also stained with trichrome for subsequent analysis of kidney structure.
Plasma was stored at À80 C for measurements of plasma renin concentration, Ang II, and Ang-(17) by radioimmunoassay (RIA) as described previously [Ferrario et al. 2005a; Ishiyama et al. 2004; Iyer et al. 1998 ]. For the measurement of angiotensin peptides, a cocktail of protease inhibitors was used for collecting blood to prevent peptide degradation and generation [Kohara et al. 1991] . Plasma renin concentration was done in blood collected in EDTA containing tubes. Plasma renin concentration was defined as the rate of Ang I generation from renin in the sample incubated at pH 6.5 for 90 min with excess exogenous substrate provided from nephrectomized rat plasma. Ang I generated in the sample was quantified by radioimmunoassay (Diosarin Corp, Stillwater, MN).
Tissue samples from the LV base were quickly frozen on dry ice. Frozen heart samples were then weighed, homogenized, and extracted using Sep-Pak columns as previously described [Senanayake et al. 1998 ]. The eluate was divided for two RIAs (Ang II and Ang-[17]), and the solvent was evaporated. Recoveries of radiolabeled angiotensin peptides added to the samples were determined following the extraction. Recovery of radiolabeled peptide averaged greater than 65% and results were corrected for recovery. Ang II was measured using the Alpco Diagnostics kit (Windham, NH). Ang-(17) was measured using an antibody produced by our laboratory and extensively documented elsewhere [Senanayake et al. 1998 ]. The minimum detectable levels (MDL) of these assays were 0.9 fmol/tube for Ang II and 1.39 fmol/tube for Ang-(17). Values at or below the MDL of the assay were assigned the value of the MDL for the respective peptide for statistical analysis.
The results were adjusted for the protein content of the sample measured by the Bio-Rad protein assay.
For immunoblotting, samples of cardiac plasma membranes were subjected to SDS-PAGE in 10% polyacrylamide gels as previously described [Shaltout et al. 2007 ]. Proteins were then transferred onto polyvinylidene difluoride membrane, and subsequently blocked for 1 h with either 5% Bio-Rad Dry Milk and tris-buffered saline (TBS) with Tween for mas and ACE2 or Starting Block Blocking Buffer (Thermo Scientific, Rockford, IL) for angiotensin type 1 receptor (AT 1 ) before incubation with primary antibodies against b-actin (1:2000; Sigma, St. Louis, MO); AT 1 (1:250; Alomone Labs, Jerusalem, Israel), mas (1:200; Alomone labs, Jerusalem, Israel), and ACE2 (1:1000; Hypertension and Vascular Disease Center No. A2405). Immunoblots were then resolved with Pierce Super Signal West Pico Chemiluminescent substrates as described by the manufacturer and exposed to Amersham Hyperfilm enhanced chemiluminescence (Piscataway, NJ).
Additional LV tissue samples from the apical portion were snap-frozen in liquid nitrogen and stored at À80 C for reverse transcriptase realtime polymerase chain reaction analysis of mRNA for AT 1 , mas and ACE2 [Ferrario et al. 2005b; Tallant et al. 2005 ]. The following primer/probe sets were used: for AT 1 , the set was purchased from Applied Biosystems (Foster City, CA); for mas, forward primer 5_-TT CATAGCCATCCTCAGCTTCTTG-3; reverse primer 5_-GTTCTTCCGTATCTTCACCACC AA-3; and probe 5_-FAM-TTCACTCCGCTC ATGT TAG-NFQ-3; for ACE2, forward primer 5_-CCCAGAGAACAGTGGACCAAAA-3; reverse primer 5_-GCTCCACCACACCAACG AT-3_; and probe -FAM-CTCCCGCTTCAT CTCC-NFQ-3. All reactions were performed in triplicate and 18S ribosomal RNA served as an internal control. The results were quantified as cycle threshold (Ct) values, where Ct is defined as the threshold cycle of PCR at which the amplified product is first detected, and expressed as the ratio of target/18S rRNA control.
Statistics
All values are expressed as the mean±1SEM. Data were analyzed by use of Student's t-test except for the systolic blood pressure analysis for which ANOVA, followed by Newman-Keuls' post-test, was used for multiple comparisons among groups. A value of p < 0.05 was considered to be of statistical significance.
Results
Effect of salt excess on blood pressure and heart weight and structure At baseline, systolic blood pressure averaged 166±3 mm Hg and 161±3 mmHg in the control and salt-loaded SHRs, respectively (p > 0.05). Exposure to a high salt diet was associated with a further increase in systolic blood pressure during the course of the experiment (Figure 1 ). Cardiac weight index (heart weight normalized to body weight) was increased in salt-loaded SHR, reflective of the increased LV posterior wall thickness (PWTd) but also, in part, of a lower body weight (Table 1) . Unlike SHR fed a normal salt diet, prominent interstitial and perivascular fibrosis was observed in the myocardium of SHR exposed to a high salt intake (Figure 2 ).
Effects of high salt intake on LV function
Echocardiographic analysis of the left ventricular structure and function is presented in Table 1 . There were no differences between control and salt-loaded SHR with respect to ESD and EDD. Fractional shortening was higher in SHR fed a high sodium diet demonstrating preserved, if not enhanced, systolic function. Doppler transmitral flow and tissue imaging revealed signs of early diastolic dysfunction in salt-loaded rats manifested by decreases in E, E/A ratio, E dec slope, and e 0 . Left ventricular filling pressure or E/e 0 and E dec time were not different between groups. Effect of salt excess on urinary protein, sodium excretion and renal histology Twenty-four-hour urinary output (50±10 versus 6±1 ml/day; p < 0.001) and urinary protein (131±33 mg/day versus 14±2 mg/day; p < 0.001) and sodium (11.1±3.1 versus 1.0±0.1 mEq/day; p < 0.001) excretion were significantly higher in salt-loaded SHR compared to SHR controls. Histological examination of the kidney revealed that salt loading induced extensive nephrosclerosis as well as tubulo-interstitial changes (Figure 3 ).
Effects of high salt intake on plasma and cardiac angiotensins
High dietary salt intake increased plasma renin and Ang II concentrations but not plasma Ang-(17) (Figure 4 ). While LV tissue Ang II content was not changed, high dietary salt intake dramatically reduced the cardiac content of Ang-(17) ( Figure 5) . Consequently, the Ang-(17)/Ang II ratio in the LV of salt-loaded SHR was reduced from 1.20±0.36 to 0.32±0.02 (p < 0.05) when compared with the rats fed a normal salt diet. Effects of salt excess on cardiac AT 1 and mas mRNA and protein levels Cardiac expression of AT 1 but not mas mRNA was reduced in SHR exposed to a high-salt diet ( Figure 6 ). Cardiac receptor protein levels for both AT 1 and mas receptors did not change.
Effects of salt excess on cardiac ACE2
Salt excess reduced cardiac expression of ACE2 mRNA and protein (Figure 7) .
Discussion
Increased salt intake in SHR worsens hypertension as well as cardiac and renal remodeling as reflected in echocardiographic and structural evidence of cardiac hypertrophy, proteinuria and collagen deposition. It was previously demonstrated that the hypertension in SHR is in part salt sensitive and associated with a loss of the appropriate downregulatory effect of dietary sodium on circulating Ang II and angiotensinogen [Hodge et al. 2002; Widimsky et al. 1991] .
We now extend these studies showing that while salt excess did not significantly affect Ang-(17) in plasma it diminished cardiac levels of Ang-(17). Thus, high salt diet altered the balance between the two peptides facilitating the vasoconstrictor, proliferative and hypertrophic actions of Ang II in the heart. These data agree with our previous demonstration that an 8% salt diet induced cardiac remodeling and dysfunction, which may be, at least in part, independent of the effect of salt intake on arterial pressure [Varagic et al. 2006; du Cailar et al. 2002 du Cailar et al. , 1989 Frohlich et al. 1993 ]. In agreement with this interpretation, concomitant treatment with an AT 1 receptor antagonist ameliorated salt-induced cardiac injury in SHR without affecting the elevated blood pressure [Varagic et al. 2008] .
Evidence suggests that Ang II exerts mitogenic and growth-promoting effects in cardiac myocytes and nonmyocytic elements and both of these actions significantly contribute to the development and progression of hypertensive heart disease [Weber and Brilla, 1991] . Indeed, in the present study salt excess was associated with further hemodynamic and structural evidence of cardiac hypertrophy and collagen deposition when compared with SHR maintained on a normal sodium intake. Although plasma renin activity may be suppressed in response to high dietary salt intake [Hodge et al. 2002; Yu et al. 1998 ], these changes were not associated with lower plasma angiotensinogen and Ang II levels [Hodge et al. 2002] , suggesting dysregulation of the Ang II response to long-term high dietary salt intake. Increased salt intake in our study was accompanied by hyper-reninemia and higher levels of circulating Ang II that may be the result of the effects of salt on renal function and structure as well, as proteinuria and acceleration of glomerulosclerosis accompanied the exposure to a high salt diet. In agreement with this interpretation, we showed that intermediate levels of high salt intake (4% and 6% NaCl in food) promoted dramatic deterioration in renal and glomerular dynamics in SHR [Matavelli et al. 2007 ]. In those studies, high salt intake induced increased afferent and efferent arteriolar resistances associated with increased glomerular hydrostatic pressure that might favor the development of nephrosclerosis and, consequently, activation of the circulating reninangiotensin system. The increased cardiac work induced by the combination of the higher salt intake and the further augmentation in afterload was associated with increased systolic indices of ventricular contractility accompanied by nonsuppressed tissue levels of Ang II and AT 1 receptor protein.
Evidence of downregulation of AT 1 receptor mRNA in the heart of salt-loaded SHR may reflect a tissue response to the activated circulatory and nonsuppressed cardiac Ang II, providing further supporting evidence of inappropriately high Ang II activity in different models of salt-sensitive hypertension [Liang and Leenen, 2007; Zhu et al. 2004; Sumida et al. 1998; Kreutz et al. 1995] .
Finally, salt loading diminished Ang-(17) level in the heart in association with reduced ACE2 mRNA and protein level. We previously showed that Ang II reduced ACE2 mRNA in cultured myocytes and fibroblasts [Gallagher et al. 2008 ]. In addition, although Ang-(17) did not affect ACE2 mRNA itself, it prevented the Ang II-mediated reduction in ACE2 mRNA in cultured cardiac cells, an effect blocked by a selective Ang-(17) receptor antagonist [Gallagher et al. 2008] . In agreement, in Dahl salt-sensitive rats fed a high salt diet, cardiac enlargement and fibrosis were associated with an increased cardiac angiotensinogen but reduced cardiac ACE2 mRNA. Tissue peptides were not determined in that study [Takeda et al. 2007 ]. To the best of our knowledge, we are the first to report a diminished level of cardiac Ang-(17) in response to salt loading. Thus, when tissue levels of Ang-(17) are decreased, the transcriptional downregulation of ACE2 by Ang II may be left unopposed. In addition, besides its vasodilatory effects, Ang- (17) mediates antihypertrophic and antiproliferative effects by binding to its specific cell membrane receptor, mas [Tallant et al. 2005 ]. Thus, Ang-(17) inhibited protein incorporation into myocytes in culture and the antitrophic effects of the peptide were prevented following administration of antisense oligonucleotides directed against the mas receptor [Tallant et al. 2005 ]. In addition, Ang-(17) reduced proline incorporation into cardiac fibroblasts, indicating that the heptapeptide also inhibits collagen synthesis as well * [ Tallant et al. 2003 ]. Furthermore, significant changes in the ACE2/Ang-(17)/mas receptor axis of the reninangiotensin system may occur in some pathological states. For example, in a congenic rat model of hypertension (mRen2.Lewis), diminished cardiac expression and activity of ACE2 were demonstrated [Jessup et al. 2006 ]. Importantly, a recent study from our laboratory revealed a predominant role of ACE2 in Ang-(17) formation in the heart of hypertensive rats [Trask et al. 2007] . Along with studies showing that Ang-(17) supplementation reduces an increase in blood pressure in Dahl salt-sensitive rats fed a high salt diet [Eatman et al. 2001] and prevents Ang II-related cardiac hypertrophy and fibrosis [Grobe et al. 2007] , our results suggest a critical role of the Ang-(17) in the development of salt-related hypertension and hypertensive heart disease.
In conclusion, salt excess increased circulating Ang II while reducing cardiac Ang-(17) shifting the balance in angiotensin peptides towards the vasoconstrictor, proliferative and prohypertrophic actions of Ang II. Our results, therefore, suggest that the adverse cardiac effects of excessive salt intake may result not only from the undesirable action of Ang II but also as a consequence of diminished protective effects of Ang-(17).
